Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
July 21, 2014
TheStreet / Powered by NewsLook.com
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.
Video provided by TheStreet
AFP (Apr. 8, 2013) South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive ... watch video
NDTV (May 7, 2013) It is not a girl's world, at least not in India where there are only 919 girls under six for every 1000 boys. The 2011 census figures show the ratio has fallen further from the already alarming 927 ... watch video
Newsy (July 10, 2014) The anonymous infant's "functional cure" last year raised hopes of a treatment for HIV-positive babies, but the virus finally re-emerged in the girl.
Video provided by ... watch video
FORA.tv (May 9, 2013) Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the ... watch video
Newsy (July 22, 2015) Eli Lilly is debuting solanezumab, its new drug designed to cure Alzheimer's. But will the drug fare better than past trials have foreshadowed?
Video provided by ... watch video
AFP (May 5, 2015) An Austrian men's magazine has printed its latest edition using blood from people who are HIV-positive in order to counter the "stigma" often attached to the virus, its chief editor said Tuesday. ... watch video
Aug. 3, 2015 Cell plasticity program resulting from kidney damage can be targeted to reverse kidney disease and fibrosis, new research suggests. The study demonstrated the importance of an embryonic cellular ... read more
Aug. 3, 2015 The first comprehensive study of its kind finds weight cycling, repeated cycles of intentional weight loss followed by regain, was not associated with overall risk of cancer in men or ... read more
Aug. 3, 2015 A bench-top brain that accurately reflects actual brain tissue would be significant for researching not only the effect of drugs, but brain disorders like schizophrenia, and degenerative brain ... read more
July 31, 2015 Two commonly used gout medications, which target uric acid and adenosine triphosphate, may offer protection from alcohol-induced liver disease and inflammation, new research suggests. These findings ... read more
Aug. 3, 2015 Abstinence is the best way to avoid drug addiction. But in many societies, drug use is the norm, not the exception, especially by youth. What keeps the majority of users from becoming addicted? How ... read more
Aug. 3, 2015 Medications commonly used to treat dementia could result in harmful weight loss, according to researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, ... read more
Mar. 31, 2015 HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and ... read more
July 23, 2014 Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new ... read more
Jan. 15, 2014 Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new ... read more
Feb. 1, 2011 Researchers examined the role of later acquisition of hepatitis C in HIV patients in a new study. The findings suggest HIV patients should have access to ongoing screening for hepatitis ... read more